Andrew Hindley

1.7k total citations
39 papers, 1.1k citations indexed

About

Andrew Hindley is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Andrew Hindley has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in Andrew Hindley's work include Head and Neck Cancer Studies (8 papers), Ovarian cancer diagnosis and treatment (6 papers) and Effects of Radiation Exposure (5 papers). Andrew Hindley is often cited by papers focused on Head and Neck Cancer Studies (8 papers), Ovarian cancer diagnosis and treatment (6 papers) and Effects of Radiation Exposure (5 papers). Andrew Hindley collaborates with scholars based in United Kingdom, New Zealand and Australia. Andrew Hindley's co-authors include Alan Lamont, James W. Denham, David S. Lamb, Nigel Spry, Ian A. Cree, Christian M. Kurbacher, Lee Tripcony, S. Susnerwala, Kinta Beaver and Karen Luker and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Biophysical Journal.

In The Last Decade

Andrew Hindley

39 papers receiving 1.0k citations

Peers

Andrew Hindley
Mary Dunne Ireland
Jie Su Canada
Sandra McDonald United States
Charles D. Haas United States
Thomas L. Riley United States
Manxia Wu United States
Mary Dunne Ireland
Andrew Hindley
Citations per year, relative to Andrew Hindley Andrew Hindley (= 1×) peers Mary Dunne

Countries citing papers authored by Andrew Hindley

Since Specialization
Citations

This map shows the geographic impact of Andrew Hindley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Hindley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Hindley more than expected).

Fields of papers citing papers by Andrew Hindley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Hindley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Hindley. The network helps show where Andrew Hindley may publish in the future.

Co-authorship network of co-authors of Andrew Hindley

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Hindley. A scholar is included among the top collaborators of Andrew Hindley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Hindley. Andrew Hindley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brown, R, Andrew Hindley, R Cuthbert, et al.. (2024). Association between JAK2V617F variable allele frequency and risk of thrombotic events in patients with myeloproliferative neoplasms. Irish Journal of Medical Science (1971 -). 193(6). 2883–2888. 2 indexed citations
2.
Hindley, Andrew, Mark Catherwood, Mary Frances McMullin, & Ken Mills. (2021). Significance of NPM1 Gene Mutations in AML. International Journal of Molecular Sciences. 22(18). 10040–10040. 25 indexed citations
3.
Hindley, Andrew, et al.. (2020). Mutational profiling in suspected triple-negative essential thrombocythaemia using targeted next-generation sequencing in a real-world cohort. Journal of Clinical Pathology. 74(12). 808–811. 12 indexed citations
4.
Catherwood, Mark, et al.. (2019). A molecular diagnostic algorithm for JAK2 V617F investigations in suspected myeloproliferative neoplasms. Irish Journal of Medical Science (1971 -). 189(2). 621–626. 3 indexed citations
6.
Golash, Aprajay, et al.. (2010). Carcinomatous change in a craniopharyngioma: a case report. 21. 1 indexed citations
7.
Beaver, Kinta, Malcolm Campbell, Susan Williamson, et al.. (2009). Comparing hospital and telephone follow-up after treatment for breast cancer: randomised equivalence trial. BMJ. 338(jan14 2). a3147–a3147. 151 indexed citations
8.
Beaver, Kinta, William Hollingworth, Ruth McDonald, et al.. (2009). 4150 Is telephone follow-up by specialist nurses a cost effective approach?. European Journal of Cancer Supplements. 7(2). 230–231. 2 indexed citations
9.
Cree, Ian A., Christian M. Kurbacher, Alan Lamont, Andrew Hindley, & Sharon Love. (2007). A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancer. Anti-Cancer Drugs. 18(9). 1093–1101. 77 indexed citations
10.
Krawitz, Hedley, et al.. (2006). T1N0/T2N0 glottic carcinoma: A comparison of two fractionation schedules. Australasian Radiology. 50(2). 152–157. 18 indexed citations
11.
German, Matthew J., Azzedine Hammiche, Narasimhan Ragavan, et al.. (2006). Infrared Spectroscopy with Multivariate Analysis Potentially Facilitates the Segregation of Different Types of Prostate Cell. Biophysical Journal. 90(10). 3783–3795. 119 indexed citations
12.
Mäenpää, Johanna, Derek Cruickshank, Jonathan A. Ledermann, et al.. (2005). SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel–irinotecan as first-line therapy for ovarian cancer. British Journal of Cancer. 94(1). 55–61. 8 indexed citations
14.
Sharma, Sanjay, Michael H. Neale, Federica Di Nicolantonio, et al.. (2003). Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma. BMC Cancer. 3(1). 19–19. 56 indexed citations
15.
Poulsen, Michael, James W. Denham, Lester J. Peters, et al.. (2001). A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study. Radiotherapy and Oncology. 60(2). 113–122. 81 indexed citations
16.
Hamilton, C.S., Michael Poulsen, Quenten Walker, et al.. (1999). Quality assurance audit in an Australasian phase III trial of accelerated radiotherapy for head and neck cancer (TROG 91.01). Australasian Radiology. 43(2). 227–232. 13 indexed citations
17.
Denham, James W., Lester J. Peters, Jørgen Johansen, et al.. (1999). Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer?. Radiotherapy and Oncology. 52(2). 157–164. 128 indexed citations
18.
McIvor, Nicholas P., et al.. (1998). Audit in the management of T3 fixed-cord laryngeal cancer. American Journal of Otolaryngology. 19(6). 360–364. 14 indexed citations
19.
Hindley, Andrew, et al.. (1998). A simple percutaneous inserter for radiopaque gold seeds used in radiotherapy treatment planning. Australasian Radiology. 42(2). 169–171. 1 indexed citations
20.
Hindley, Andrew, et al.. (1990). ‘Watch policy’ in patients with suspected stage I testicular seminoma: CT as a sole staging and surveillance technique. Clinical Radiology. 42(1). 40–41. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026